申请人:Zhang Han-Cheng
公开号:US20090176806A1
公开(公告)日:2009-07-09
The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
本发明涉及用作激酶抑制剂的新型取代吡咯烷化合物及治疗或改善激酶介导的疾病的方法。